Literature DB >> 27524653

Alternatives to overcoming bacterial resistances: State-of-the-art.

Alessandra C Rios1, Carla G Moutinho2, Flávio C Pinto3, Fernando S Del Fiol1, Angela Jozala1, Marco V Chaud1, Marta M D C Vila1, José A Teixeira4, Victor M Balcão5.   

Abstract

Worldwide, bacterial resistance to chemical antibiotics has reached such a high level that endangers public health. Presently, the adoption of alternative strategies that promote the elimination of resistant microbial strains from the environment is of utmost importance. This review discusses and analyses several (potential) alternative strategies to current chemical antibiotics. Bacteriophage (or phage) therapy, although not new, makes use of strictly lytic phage particles as an alternative, or a complement, in the antimicrobial treatment of bacterial infections. It is being rediscovered as a safe method, because these biological entities devoid of any metabolic machinery do not possess any affinity whatsoever to eukaryotic cells. Lysin therapy is also recognized as an innovative antimicrobial therapeutic option, since the topical administration of preparations containing purified recombinant lysins with amounts in the order of nanograms, in infections caused by Gram-positive bacteria, demonstrated a high therapeutic potential by causing immediate lysis of the target bacterial cells. Additionally, this therapy exhibits the potential to act synergistically when combined with certain chemical antibiotics already available on the market. Another potential alternative antimicrobial therapy is based on the use of antimicrobial peptides (AMPs), amphiphilic polypeptides that cause disruption of the bacterial membrane and can be used in the treatment of bacterial, fungal and viral infections, in the prevention of biofilm formation, and as antitumoral agents. Interestingly, bacteriocins are a common strategy of bacterial defense against other bacterial agents, eliminating the potential opponents of the former and increasing the number of available nutrients in the environment for their own growth. They can be applied in the food industry as biopreservatives and as probiotics, and also in fighting multi-resistant bacterial strains. The use of antibacterial antibodies promises to be extremely safe and effective. Additionally, vaccination emerges as one of the most promising preventive strategies. All these will be tackled in detail in this review paper.
Copyright © 2016. Published by Elsevier GmbH.

Entities:  

Keywords:  Alternatives to conventional antibiotics; Antibiotics; Antibodies and vaccines; Antimicrobial peptides and bacteriocins; Bacterial resistance; Bacteriophages and phage therapy; Lysin therapy

Mesh:

Year:  2016        PMID: 27524653     DOI: 10.1016/j.micres.2016.04.008

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  51 in total

1.  A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.

Authors:  ZhaoFei Wang; LiCheng Kong; Yang Liu; Qiang Fu; ZeLin Cui; Jian Wang; JingJiao Ma; HengAn Wang; YaXian Yan; JianHe Sun
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

Review 2.  Gain and loss of antibiotic resistant genes in multidrug resistant bacteria: One Health perspective.

Authors:  Misung Kim; Jaeeun Park; Mingyeong Kang; Jihye Yang; Woojun Park
Journal:  J Microbiol       Date:  2021-04-20       Impact factor: 3.422

3.  Spinal Cord Injury Creates Unique Challenges in Diagnosis and Management of Catheter-Associated Urinary Tract Infection.

Authors:  Felicia Skelton-Dudley; James Doan; Katie Suda; S Ann Holmes; Charlesnika Evans; Barbara Trautner
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

4.  Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom.

Authors:  Clara Pérez-Peinado; Susana Almeida Dias; Marco M Domingues; Aurélie H Benfield; João Miguel Freire; Gandhi Rádis-Baptista; Diana Gaspar; Miguel A R B Castanho; David J Craik; Sónia Troeira Henriques; Ana Salomé Veiga; David Andreu
Journal:  J Biol Chem       Date:  2017-12-18       Impact factor: 5.157

5.  Recombination of T4-like Phages and Its Activity against Pathogenic Escherichia coli in Planktonic and Biofilm Forms.

Authors:  Min Li; Donglin Shi; Yanxiu Li; Yuyi Xiao; Mianmian Chen; Liang Chen; Hong Du; Wei Zhang
Journal:  Virol Sin       Date:  2020-05-25       Impact factor: 4.327

6.  Antibacterial peptide NZ2114-loaded hydrogel accelerates Staphylococcus aureus-infected wound healing.

Authors:  Yan Huang; Na Yang; Da Teng; Ruoyu Mao; Ya Hao; Xuanxuan Ma; Lingyun Wei; Jianhua Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-07       Impact factor: 4.813

7.  Genome Sequencing and Analysis of Bacillus pumilus ICVB403 Isolated from Acartia tonsa Copepod Eggs Revealed Surfactin and Bacteriocin Production: Insights on Anti-Staphylococcus Activity.

Authors:  Mahammed Zidour; Yanath Belguesmia; Benoit Cudennec; Thierry Grard; Christophe Flahaut; Sami Souissi; Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

Review 8.  Kiwifruit bacterial canker: an integrative view focused on biocontrol strategies.

Authors:  Carla Pereira; Pedro Costa; Larindja Pinheiro; Victor M Balcão; Adelaide Almeida
Journal:  Planta       Date:  2021-01-27       Impact factor: 4.116

9.  Overview of the actions to combat bacterial resistance in large hospitals.

Authors:  Mariana Sanches de Mello; Adriana Cristina Oliveira
Journal:  Rev Lat Am Enfermagem       Date:  2021-04-09

10.  Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against Acinetobacter baumannii.

Authors:  Min Ji Hong; Min Kyung Kim; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.